Moderna Asks FDA to Authorize Its COVID-19 Vaccine for Children Under 6
Preliminary analysis indicates vaccine efficacy of 51 percent among children younger than 2 years and 37 percent among children 2 to 5 years
Shared Genetic Variants for COVID-19 Severity, Medical Conditions ID’d
Other medical conditions have associations with the same genetic variants associated with COVID-19 severity
E.U. Says Europe Out of ‘Emergency’ Phase of Pandemic
Announcement is not binding and national governments within the European Union will still be able to set their own public health policies
Medicare Advantage Plans Often Deny Coverage for Eligible, Necessary Care: Report
About 28 million older Americans have Medicare Advantage plans
Hospital Outcomes Worse With Suboptimal Treatment of Hypothyroidism
Patients with clinical hypothyroidism and a high prehospitalization TSH level had longer length of stay, increased risk for readmission
Vaccination Cuts Severe COVID-19 Risk in Heart Transplant Patients
COVID-19 vaccination is not associated with heart transplant-specific adverse events
SARS-CoV-2 Seroprevalence Up From Dec. 2021 to Feb. 2022
By February 2022, seroprevalence reached 75.2 percent among children aged 0 to 11 years, 74.2 percent for teens aged 12 to 17 years
U.S. Teen Suicides Up During Pandemic
Authors say interventions to alleviate downstream consequences of the pandemic are needed
RSV Prefusion F Protein-Based Immunization Studied in Pregnancy
Bivalent RSVpreF vaccine given during pregnancy elicits neutralizing antibody responses with efficient transplacental transfer
Pfizer Seeks FDA Approval of COVID-19 Boosters for Children Ages 5 to 11
Initial two-dose series of the Pfizer vaccine was authorized for that age group in October
